Contact Lenses - Medical Devices Pipeline Assessment, 2020

Contact Lenses - Medical Devices Pipeline Assessment, 2020



This Medical Devices sector report, Contact Lenses - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Contact Lenses pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Contact lens is a lightweight corrective, cosmetic or therapeutic device that is usually placed directly onto the cornea of the eye. Contact lenses covered under this segment include soft contact lens, rigid gas permeable contact lenses and hybrid contact lenses.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Contact Lenses under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Contact Lenses and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Contact Lenses under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date



2 Introduction
2.1 Contact Lenses Overview
3 Products under Development
3.1 Contact Lenses - Pipeline Products by Stage of Development
3.2 Contact Lenses - Pipeline Products by Segment
3.3 Contact Lenses - Pipeline Products by Territory
3.4 Contact Lenses - Pipeline Products by Regulatory Path
3.5 Contact Lenses - Pipeline Products by Estimated Approval Date
3.6 Contact Lenses - Ongoing Clinical Trials
4 Contact Lenses - Pipeline Products under Development by Companies
4.1 Contact Lenses Companies - Pipeline Products by Stage of Development
4.2 Contact Lenses - Pipeline Products by Stage of Development
5 Contact Lenses Companies and Product Overview
5.1 Aeon Astron Corporation Company Overview
5.1.1 Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.2 Ai Kangte Medical Technology Co Ltd Company Overview
5.2.1 Ai Kangte Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.3 Alcon Inc Company Overview
5.3.1 Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Apeliotus Ophthalmics (Inactive) Company Overview
5.4.1 Apeliotus Ophthalmics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.5 Axcelon Biopolymers Corp. Company Overview
5.5.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview
5.6 Azalea Vision Company Overview
5.6.1 Azalea Vision Pipeline Products & Ongoing Clinical Trials Overview
5.7 Bar-Ilan University Company Overview
5.7.1 Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview
5.8 Bausch & Lomb Inc Company Overview
5.8.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Bionode LLC Company Overview
5.9.1 Bionode LLC Pipeline Products & Ongoing Clinical Trials Overview
5.10 Clerio Vision Inc Company Overview
5.10.1 Clerio Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 CooperVision Inc Company Overview
5.11.1 CooperVision Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Euclid Systems Corp Company Overview
5.12.1 Euclid Systems Corp Pipeline Products & Ongoing Clinical Trials Overview
5.13 e-Vision Medical Devices, Inc. Company Overview
5.13.1 e-Vision Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.14 Eyenovations Company Overview
5.14.1 Eyenovations Pipeline Products & Ongoing Clinical Trials Overview
5.15 EyeYon Medical Company Overview
5.15.1 EyeYon Medical Pipeline Products & Ongoing Clinical Trials Overview
5.16 Imperial College London Company Overview
5.16.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
5.17 Industrial Science & Technology Network Inc Company Overview
5.17.1 Industrial Science & Technology Network Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 Innovega Inc Company Overview
5.18.1 Innovega Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Johnson & Johnson Vision Care Inc Company Overview
5.19.1 Johnson & Johnson Vision Care Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 Kubota Vision Inc Company Overview
5.20.1 Kubota Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 Lipocoat BV Company Overview
5.21.1 Lipocoat BV Pipeline Products & Ongoing Clinical Trials Overview
5.22 Lynthera Corp Company Overview
5.22.1 Lynthera Corp Pipeline Products & Ongoing Clinical Trials Overview
5.23 Massachusetts Eye and Ear Infirmary Company Overview
5.23.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview
5.24 McGowan Institute for Regenerative Medicine Company Overview
5.24.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview
5.25 Mojo Vision Inc Company Overview
5.25.1 Mojo Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
5.26 National University of Singapore Company Overview
5.26.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview
5.27 Novartis AG Company Overview
5.27.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
5.28 Ocular Dynamics, LLC Company Overview
5.28.1 Ocular Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.29 OcuMedic Inc Company Overview
5.29.1 OcuMedic Inc Pipeline Products & Ongoing Clinical Trials Overview
5.30 Ocutec Ltd Company Overview
5.30.1 Ocutec Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.31 RetMap Inc Company Overview
5.31.1 RetMap Inc Pipeline Products & Ongoing Clinical Trials Overview
5.32 Shamir Optical Industry Ltd Company Overview
5.32.1 Shamir Optical Industry Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.33 SightGlass Vision Inc Company Overview
5.33.1 SightGlass Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
5.34 Stanford University Company Overview
5.34.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
5.35 TECLens LLC Company Overview
5.35.1 TECLens LLC Pipeline Products & Ongoing Clinical Trials Overview
5.36 The University of New South Wales press Limited Company Overview
5.36.1 The University of New South Wales press Limited Pipeline Products & Ongoing Clinical Trials Overview
5.37 University of California San Diego Company Overview
5.37.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
5.38 University of Florida Company Overview
5.38.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
5.39 University of New Hampshire Company Overview
5.39.1 University of New Hampshire Pipeline Products & Ongoing Clinical Trials Overview
5.40 University of Valencia Company Overview
5.40.1 University of Valencia Pipeline Products & Ongoing Clinical Trials Overview
5.41 University of Washington Company Overview
5.41.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview
5.42 Verily Life Sciences Company Overview
5.42.1 Verily Life Sciences Pipeline Products & Ongoing Clinical Trials Overview
5.43 Visioneering Technologies Inc Company Overview
5.43.1 Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.44 VISTAKON Pharmaceuticals LLC Company Overview
5.44.1 VISTAKON Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview
5.45 Yolia Health Company Overview
5.45.1 Yolia Health Pipeline Products & Ongoing Clinical Trials Overview
6 Contact Lenses- Recent Developments
6.1 Nov 12, 2020: Bausch + Lomb reports nearly 27 million units of contact lens materials recycled through one by one recycling program
6.2 Oct 01, 2020: Essilor and Quisitive employ rapid application development to adapt to new operational norms
6.3 Sep 10, 2020: CooperCompanies and Divisions named one of Fortunes Best Large Workplaces in Manufacturing and Production
6.4 Sep 07, 2020: Visioneering sees continued recovery
6.5 Sep 04, 2020: EssilorLuxottica : Update on legal proceedings to obtain information from GrandVision
6.6 Sep 01, 2020: Novartis announces ambitious ESG targets to increase access to medicines and achieve full carbon neutrality
6.7 Aug 18, 2020: Johnson & Johnson Vision announces new ACUVUE services and resources to enhance contact lens safety, comfort, and accessibility as part of contact lens health week
6.8 Jun 30, 2020: Menicon: A business tie-up agreement concluded with Chinas Wenzhou Medical University
6.9 Jun 25, 2020: SEC charges Novartis with FCPA violations
6.10 Apr 24, 2020: Menicon announces completion of floor space expansion at its Kakamigahara Plant
6.11 Apr 20, 2020: EssilorLuxottica to prepare for recovery by preserving cash and supporting employees
6.12 Apr 13, 2020: New research reassures & advises contact lens wearers during COVID-19 pandemic; offers clear facts and hygiene advice
6.13 Apr 07, 2020: Alcon provides update on covid-19
6.14 Mar 13, 2020: Bausch Health to reduce debt by approximately $100 million using cash generated from operations
6.15 Mar 06, 2020: Pentax Medical donates USD430,000 worth of medical devices to fight novel corona virus (2019-ncov)
6.16 Mar 04, 2020: High-Tech contact lenses correct color blindness
6.17 Mar 02, 2020: Alcon showcases contact lens, eye allergy and dry eye innovations as title sponsor of SECO2020
6.18 Feb 07, 2020: CooperCompanies appoints Mark Drury as new vice president, general counsel and corporate secretary and announces Randal L. Golden to retire
6.19 Feb 06, 2020: Mature presbyopes clinical research update presented at Global Specialty Lens Symposium (GSLS)
6.20 Feb 04, 2020: Visioneering Technologies achieves first sale in Singapore as Asian expansion accelerates
6.21 Jan 29, 2020: Novartis delivered strong sales growth, margin expansion and breakthrough innovation launching five NMEs in 2019
6.22 Jan 27, 2020: Bausch + Lomb and TerraCycle partner to launch Canadas first and only contact lens recycling program
6.23 Jan 22, 2020: Novartis establishes its new legal entity in Vietnam
6.24 Jan 16, 2020: Mojo Vision developing first true smart contact lens
6.25 Jan 16, 2020: Mojo Vision working with FDA, nonprofit organization to assist people with low vision
6.26 Jan 06, 2020: Bausch + Lomb launches expanded parameters for Biotrue ONEday for Astigmatism Daily Disposable Contact Lenses
6.27 Dec 16, 2019: Bausch Health Resolves ""Stock Drop"" Litigation initially filed in October 2015
6.28 Dec 06, 2019: FDA approves Myopia-slowing contact lens for children
6.29 Dec 05, 2019: Novartis expects to sustain long-term growth with a robust pipeline of 25+ potential blockbusters highlighted at R&D Day
6.30 Dec 05, 2019: CooperCompanies announces fourth quarter and full year 2019 results
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List Of Tables


Table 1: Contact Lenses - Pipeline Products by Stage of Development
Table 2: Contact Lenses - Pipeline Products by Segment
Table 3: Contact Lenses - Pipeline Products by Territory
Table 4: Contact Lenses - Pipeline Products by Regulatory Path
Table 5: Contact Lenses - Pipeline Products by Estimated Approval Date
Table 6: Contact Lenses - Ongoing Clinical Trials
Table 7: Contact Lenses Companies - Pipeline Products by Stage of Development
Table 8: Contact Lenses - Pipeline Products by Stage of Development
Table 9: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Biolens - Product Status
Table 11: Biolens - Product Description
Table 12: Contact Lens - Product Status
Table 13: Contact Lens - Product Description
Table 14: Ai Kangte Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Multifocal Contact Lens (Muti-Focal RGP) - Myopia - Product Status
Table 16: Multifocal Contact Lens (Muti-Focal RGP) - Myopia - Product Description
Table 17: Multifocal Contact Lens (Muti-Focal RGP) - Ocular Surface Disease - Product Status
Table 18: Multifocal Contact Lens (Muti-Focal RGP) - Ocular Surface Disease - Product Description
Table 19: Multifocal Contact Lens (Muti-Focal RGP) - Vision Correction - Product Status
Table 20: Multifocal Contact Lens (Muti-Focal RGP) - Vision Correction - Product Description
Table 21: Orthokeratology Lens - Myopia - Product Status
Table 22: Orthokeratology Lens - Myopia - Product Description
Table 23: Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Air Optix Plus HydraGlyde Toric Reusable Lens - Product Status
Table 25: Air Optix Plus HydraGlyde Toric Reusable Lens - Product Description
Table 26: Dailies Total 1 Colors SiHy Lens - Product Status
Table 27: Dailies Total 1 Colors SiHy Lens - Product Description
Table 28: Dailies Total 1 Precision 1 Toric SiHy Lens - Product Status
Table 29: Dailies Total 1 Precision 1 Toric SiHy Lens - Product Description
Table 30: Weekly WG SiHy Lens - Product Status
Table 31: Weekly WG SiHy Lens - Product Description
Table 32: Apeliotus Ophthalmics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Comfort Lens - Product Status
Table 34: Comfort Lens - Product Description
Table 35: Contact Lens - Glaucoma - Product Status
Table 36: Contact Lens - Glaucoma - Product Description
Table 37: Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview
Table 38: PolyHEMA-BNC Based Contact Lens - Product Status
Table 39: PolyHEMA-BNC Based Contact Lens - Product Description
Table 40: Azalea Vision Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Smart Contact Lens - Product Status
Table 42: Smart Contact Lens - Product Description
Table 43: Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Bionic Contact Lens - Product Status
Table 45: Bionic Contact Lens - Product Description
Table 46: Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Aqualox SiHy Daily Lens - Product Status
Table 48: Aqualox SiHy Daily Lens - Product Description
Table 49: Bausch + Lomb ULTRA Presbyopia Contact Lens - Product Status
Table 50: Bausch + Lomb ULTRA Presbyopia Contact Lens - Product Description

List Of Figures


Figure 1: Contact Lenses - Pipeline Products by Stage of Development
Figure 2: Contact Lenses - Pipeline Products by Segment
Figure 3: Contact Lenses - Pipeline Products by Territory
Figure 4: Contact Lenses - Pipeline Products by Regulatory Path
Figure 5: Contact Lenses - Pipeline Products by Estimated Approval Date
Figure 6: Contact Lenses - Ongoing Clinical Trials

Global Blood Contacting Medical Devices Market Research Report 2021-2025

Bloodcontacting medical devices, such as vascular grafts, stents, and heart valves, are widely used to treat cardiovascular diseases. In the context of China-US trade war and COVID-19 epidemic, it will

USD 3200 View Report

Global Contact Lenses Market, By Modality (Reusable, v/s Disposable), By Design (Spherical, Toric, Multifocal & Others), By Material Type (Silicon hydrogel, Hydrogel, Gas Permeable & others), By Application (Corrective, Therapeutic, Cosmetic & others), By Distribution (Retail Stores, Hospitals & Clinics, Online) By Region, Competition, Forecast & Opportunities, 2026

The global contact lenses market stood at USD13.73 billion in 2020 and is further anticipated to grow at a CAGR of 6.25%, during the forecast period owing to the growing geriatric population suffering from various kinds of eye related disorders.

USD 4450 View Report

Global Contact Lenses Market, By Modality (Reusable, v/s Disposable), By Design (Spherical, Toric, Multifocal & Others), By Material Type (Silicon hydrogel, Hydrogel, Gas Permeable & others), By Application (Corrective, Therapeutic, Cosmetic & others), By Distribution (Retail Stores, Hospitals & Clinics, Online) By Region, Competition, Forecast & Opportunities, 2026

The global contact lenses market stood at USD13.73 billion in 2020 and is further anticipated to grow at a CAGR of 6.25%, during the forecast period owing to the growing geriatric population suffering from various kinds of eye related disorders.

USD 4450 View Report

Global Contact Lenses and Solutions Market Research Report 2020-2024

Contact lens, or simply contacts, are thin lenses placed directly on the surface of the eyes. In the context of China-US trade war and COVID-19 epidemic, it will have a

USD 2850 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available